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ABSTRACT
Using full-length cDNA sequences, we compared
alternative splicing (AS) in humans and mice. The
alignment of the human and mouse genomes
showed that 86% of 199 426 total exons in human
AS variants were conserved in the mouse genome.
Of the 20 392 total human AS variants, however, 59%
consisted of all conserved exons. Comparing AS
patterns between human and mouse transcripts
revealed that only 431 transcripts from 189 loci
were perfectly conserved AS variants. To exclude
the possibility that the full-length human cDNAs
used in the present study, especially those with
retained introns, were cloning artefacts or prema-
turely spliced transcripts, we experimentally vali-
dated 34 such cases. Our results indicate that
even retained-intron type transcripts are typically
expressed in a highly controlled manner and interact
with translating ribosomes. We found non-
conserved AS exons to be predominantly outside
the coding sequences (CDSs). This suggests
that non-conserved exons in the CDSs of transcripts
cause functional constraint. These findings
should enhance our understanding of the relation-
ship between AS and species specificity of human
genes.
INTRODUCTION
Alternative splicing (AS), the recombination of exons to
produce novel transcripts, is thought to contribute sub-
stantially to the functional complexity of human proteins.
AS frequently produces diverse transcripts from a single
genetic locus. The consequent exon changes alter the cor-
responding amino acid sequences and generate function-
ally divergent proteins. The ENCODE and GENCODE
projects have found that about 60% of all loci encode AS
isoforms, with an average of more than 5.4 isoforms per
locus (1–3). In the ENCODE project, a product consisting
of two exons of the DONSON gene and three exons of the
ATP50 gene was cloned and sequenced by real-time
reverse transcriptase polymerase chain reaction (RT–
PCR) to generate several novel connected transcripts.
Because many transcripts are derived from non-conserved
sequences, however, the investigators in those projects
emphasized the need for further studies exploring the neu-
trality of genome evolution. Several other reports have
suggested that frequently occurring AS isoforms are not
evolutionarily conserved and thus may be attributable to
transcriptional noise or cloning artefacts.
Analyses of AS have relied on partially sequenced
cDNA information (i.e. on expressed sequence tags, or
ESTs). Although EST-based genome-wide approaches
have identiﬁed thousands of instances of AS in human
genetic transcripts (4,5), they do not provide information
about the positions and combinations of AS exons in
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detailed analysis of the impact of AS on protein function
and evolutionary turnover. Furthermore, the standard
methods for estimating selective pressure by calculating
and comparing the rates of synonymous and non-
synonymous substitutions are not easily applied to par-
tially sequenced cDNA.
In the work reported here, we collected and analysed
instances of AS in the context of full-length cDNAs, which
are ideal resources with which to analyse AS because
information regarding the complete form of a particular
transcription unit (i.e. an isoform) allows us to determine
the relevance of AS to conserved protein functions. The
functional domains of proteins are often embedded over
a wide region of the protein sequences, so it is possible
that not every combination of AS exons is allowed. Full-
length cDNA-based approaches also facilitate better cov-
erage at the 50-ends of AS sequences than do EST-based
approaches. Our data are based on a large collection of
physical cDNA clones whose complete sequences have
been determined and therefore can thus be used to directly
validate the functions of certain genes. In a previous
study, we analyzed 56419 full-length human cDNAs
whose sequences were checked by expert scientists and
by using computational methods speciﬁc to the full-
length cDNA annotation conferences H-Invitational
(H-Inv) (6) and H-Inv 2 (7). From that dataset, we created
a catalogue of 18297 AS variants at 6877 loci (8).
Our AS catalogue is not the perfect tool with which to
understand the functional diversity of human genes.
Information about evolutionary conservation must be
added to our functional annotations if one is to use our
catalogue to ascertain which of the AS sequences in spe-
ciﬁc parts of proteins should be prioritized in future func-
tional analyses. Many studies have demonstrated that a
signiﬁcant proportion of AS sequences are not conserved,
and those sequences can be assumed to have species-
speciﬁc biological roles. Also, it is suggested that not a
few genes seem to exist in a species-speciﬁc manner. We
therefore compared human AS variants with AS variants
in the mouse genome. We selected 431 conserved AS var-
iants at 189 loci for which full-length human and mouse
cDNAs were available. Interestingly, a signiﬁcant number
of the AS variants that were not directly supported by full-
length mouse cDNAs, which contained non-conserved
exons, were translated to proteins. Here, we compare the
evolutionary conservation of AS transcripts in humans
and mice by using full-length cDNAs.
MATERIALS AND METHODS
Full-length cDNA sequences fromhumans and mice
We obtained 64 034 full-length human cDNAs sequenced
in four projects—Human Unidentiﬁed Gene-Encoded
Large Proteins (HUGE), Full-Length cDNA Japan
(FLJ), Munich Information Centre for Protein
Sequences (MIPS) and Mammalian Gene Collection
(MGC)—involving six institutions: Kazusa DNA
Research Institute, Tokyo University, Helix Research
Institute, German Cancer Research Centre, the United
States National Institutes of Health and the Chinese
National Human Genome Centre. These institutions pro-
vided full-length human cDNA clones that had been
annotated at the H-Inv and H-Inv 2 conferences (Supple-
mentary Table 1A). We also obtained 118 775 full-length
mouse cDNAs that had been sequenced in the Functional
Annotation of Mouse (FANTOM) 3 and MGC projects
(Supplementary Table 1B). All sequences are registered in
release 66 of the DNA Data Bank of Japan (DDBJ) and
are freely available at http://www.ddbj.nig.ac.jp/.
Identification of human alternatively splicedvariants
Human AS variants were identiﬁed as previously
described (8). To remove potential 50-o r3 0-truncated
cDNAs, we excluded sequences with 50-o r3 0-ends in the
second or downstream exons of other sequences. We
included cDNAs with 50-o r3 0-ends in the ﬁrst or last
exon and which were therefore considered to vary in
their transcriptional initiation or termination sites. We
assumed that cDNAs with 50-ends outside the exonic
regions of other sequences were not truncated forms of
known transcripts. For a detailed discussion of this
topic, see Kimura et al. (9). The resulting set of putative
full-length cDNAs was used to compare the genomic posi-
tions of each exon–intron boundary with that of other
transcripts from the same locus, with an allowance of
10bp to remove potential sequencing or mapping errors
(Supplementary Table 2). If part of the cDNA exonic
sequence was in the ﬁrst or last exon of another cDNA
intronic region, that sequence was considered a ‘50/30-end’
AS variant. If part of the internal cDNA exonic sequence
was in the conﬁrmed intronic region of another cDNA,
then that sequence was considered an ‘internal’ AS var-
iant. We then removed annotated genomic ‘rearrange-
ment’ genes, such as those encoding immunoglobulin
(Ig) and the T-cell receptor (TCR) and anomalously
highly polymorphic genes, such as those of the major his-
tocompatibility complex (MHC). If a group of AS var-
iants contained two or more variants with the same
genomic structure, the one of median length was selected
as a representative of the group. If the number of variants
in the group is even, then the longer of the two near-
median-length variants was selected as a representative
of the group.
Functional annotation ofhuman ASisoforms
We identiﬁed AS variants containing full-length open
reading frames (ORFs), which means the start codon
(ATG) encoded methionine and the ﬁnal codon was
TAA, TAG or TGA. Full-length ORFs were deﬁned as
coding sequences (CDSs). Of the 20392 representative
human AS variants, 16103 transcripts (i.e. 14597 AS var-
iants) were determined to be isoforms with CDSs. Four
types of protein functions in these transcripts were anno-
tated: protein motifs, gene ontology (GO) terms, sub-cel-
lular localization signals and transmembrane domains.
Protein motifs and GO terms were identiﬁed with
InterProScan (10); sub-cellular localization signals were
predicted with WoLF PSORT (11) and TargetP (12) and
transmembrane domains were predicted with TMHMM
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of protein function were automatically executed by TACT
(15), an integrated annotation tool for genome and tran-
scriptome analyses. Further details regarding the func-
tional annotation pipeline are available from H-InvDB
(http://www.h-invitational.jp/) (16). The results of the
computational identiﬁcation and annotation analyses
were visually inspected by members of the AS annotation
team of H-Inv. Controversial annotations were ﬂagged to
identify possible errors.
Detectionof retrotransposons andexonic splicing enhancers
inhuman AS variants
RepeatMasker [A. F. A. Smit, R. Hubley and P. Green,
RepeatMasker Open-3.0. 1996 to 2004 http://www.repeat
masker.org)] was used to detect retrotransposons [long
terminal repeats (LTRs), long interspersed nuclear ele-
ments (LINEs) and short interspersed nuclear elements
(SINEs)] in the DNA sequences of human AS variants.
Exonic splicing enhancers (ESEs) were detected in the
DNA sequences of human AS variants by using 238 can-
didate hexamer sequences obtained from the RESCUE-
ESE Web Server (17).
Alignment ofthe human and mouse genomes
Human and mouse genome sequences (versions hg18 and
mm8) were downloaded from UCSC (http://genome.uc
sc.edu/) and a modiﬁed pairwise genome alignment was
constructed using BLASTZ (18) version 7, with parameter
C=2. Regions of redundant alignment were removed
using reciprocal best hits. This method was originally
used to construct two satellite databases of H-InvDB:
the comparative genomics database G-compass (19) and
the orthologue database Evola (20).
Genomic comparison ofhuman AS variants and the
mouse genome
The human–mouse genome alignment was used to com-
pare the position of each human AS variant exon with that
of the corresponding exon in mice. If the mapped coverage
and identity of the overlapping regions surrounding the
full-length or CDS in the exon exceeded threshold values
(70% for coverage and 60% for identity), the region was
considered ‘genome-conserved’. If the full-length or CDS
in the exon corresponded to a mouse counterpart tran-
script with coverage and identity equal to or greater
than the threshold values, this region was considered
‘transcript-conserved’. If the exon did not map to the
genome alignment, or if the mapped coverage or identity
was less than the threshold value, the exon was considered
‘non-conserved’ (Figure 1A).
The exon information was used to determine the
conservation category for each transcript. If at least one
non-conserved exon was identiﬁed in the transcript, the
transcript was considered ‘non-conserved’. If the tran-
script had no non-conserved exons but contained
genome-conserved exons, it was considered ‘genome-
conserved’. If the transcript had only transcript-
conserved exons, it was considered ‘transcript-conserved’
(Figure 1B). If all the exons in the human and mouse
transcripts were transcript-conserved and the exon combi-
nation was also conserved, the corresponding transcripts
were deﬁned as equally spliced variants (ESVs). Finally, if
diﬀerent ESVs were identiﬁed at a particular human and
mouse locus, the transcripts were considered ‘conserved
AS’ (Figure 1C).
Experimental validation of‘retained-intron’ ASsequences
Polysomal fractions were prepared, using  3 10
7 cells,
as described elsewhere (21). Cell pellets were suspended in
1ml of lysis buﬀer [20mM Tris–HCl (pH 7.5), 10mM
NaCl, 3mM MgCl2, 0.04M sucrose, 0.5% NP40 and
1mM dithiothreitol] containing 100 units of RNase inhi-
bitor. The pellets were then lysed by incubation on ice for
10min. The nuclei and cell debris were removed by cen-
trifugation at 1000g for 10min at 48C. The lysate was
layered on top of 11ml of a 15%/50% (w/v) sucrose gra-
dient and centrifuged at 36000g in a Beckman SW41Ti
Figure 1. Comparative analysis of human and mouse AS sequences.
(A) Categories of conserved exons. Full-length exons and coding regions
of exons were included in the analysis, and the highest conservation level
was selected. Boxes indicate exons; thin straight lines indicate introns.
(B) Categories of conserved AS variants within the categorized exons in
(A). Conservation levels were determined from the lowest conservation
level of each transcript’s exons. (C) Equally spliced variants (ESVs) and
conserved AS sequences represent higher categories of transcript-con-
served variants. ESVs are transcript-conserved variants with similar com-
binations of exons in diﬀerent species. Conserved AS sequences are two or
more diﬀerent ESV pairs at a particular locus in multiple species.
Additional details are available in the Results section and the Materials
and methods section.
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(Towa Labo, Japan, Model 152–001) was used to separate
the gradient into 11 equal fractions. Absorbance was mon-
itored at 260nm. Each fraction was treated with protei-
nase K. RNA was extracted using phenol and CHCl3,
precipitated with ethanol and analysed for each mRNA
species.
First-strand cDNA synthesis was performed using a 17-
bp dT primer and SuperScript II as directed by the man-
ufacturer. The resulting cDNAs were quantiﬁed and used
in quantitative RT–PCR analysis. The results were nor-
malized to the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) PCR product. PCR-cycling parameters were
508C for 2min, 958C for 10min, followed by 35 cycles
of 958C for 30s, 578C for 1min and 728C for 1min. The
ABI PRISM HT7000 Sequence Detection System
(Applied Biosystems) was used to detect the products.
The primers used in the RT–PCR are described in
Supplementary Table 3A. The sizes and integrity (the
degree of smeared amplicons and primer dimers) of the
ﬁnal PCR products were conﬁrmed by agarose gel
electrophoresis.
RESULTS
Generation and characterization of evolutionarily
conserved ASsequences
Evolutionarily conserved AS sequences were selected from
the H-Inv and H-Inv 2 datasets. We examined the evolu-
tionary conservation of exons in 20 392 AS variants of 64
034 human full-length cDNAs. The exons were deﬁned as
‘conserved’, when the human genomic sequence to which
the full-length or CDS regions of the exons were mapped
could be aligned with the mouse genome with a coverage
of >70% and an identity of >60%. Human–mouse align-
ments were performed using information available in the
UCSC Genome Browser (versions hg18 and mm8). Of the
199 426 total exons, 171 547 (86%) were categorized as
conserved (Table 1, panel A). Moreover, the exons in 12
096 transcripts of the 20 392 AS sequence variants were
categorized as genome- or transcript-conserved (Table 1,
panel B). On the other hand, in 944 human transcripts, all
of the exons were not conserved. Therefore, the locus itself
seemed not conserved. Although we did not analyze such
putatively human-speciﬁc loci separately, they should be
studied in greater detail (also see Supplementary Table 4).
The human transcripts were further examined to deter-
mine whether corresponding transcripts existed in mice.
For this purpose, 118775 full-length mouse cDNAs were
collected and annotated during the FANTOM 3 and
MGC projects to determine if any exons within the full-
length mouse cDNAs mapped to corresponding genomic
regions in humans. The conserved exons described above
were separated into transcript-conserved and genome-
conserved categories, if the coverage and identity of
the mouse counterpart exon was more than the thresh-
old value (Figure 1A). A transcript consisting of all
transcript-conserved exons was deemed to be transcript-
conserved (Figure 1B). The ESVs, in which all of the exons
and their combinations were conserved, and the conserved
AS sequences, in which both of the AS variants were
ESVs, were more highly conserved categories of tran-
script-conserved variants (Figure 1C). These categories
are explained in more detail in the Materials and methods
section.
We then identiﬁed 4624 ESVs from 3570 loci and deter-
mined that only 431 AS variants from 189 loci were con-
served (Table 1, panel C). Because these AS variants will
undoubtedly prove interesting in future investigations, we
conﬁrmed their CDSs and looked for alternative splicing-
mediated changes in the corresponding protein sequences
and for the presence of protein motifs, GO terms, subcel-
lular localization signals and transmembrane domains
within the aﬀected regions.
Examplesof evolutionarily conservedAS sequences
An example of a conserved AS sequence is shown in
Figure 2A. At the locus encoding the phosphoinositide-
3-kinase (PI3-kinase) regulatory subunit, the 50-exons of
BC094795 are AS relative to another variant, BC030815.
These human-transcript variants correspond to the
mouse-transcript variants BC026146 and BC051106,
respectively. All of the exons as well as their combinations
and AS patterns are conserved in each of the human–
mouse transcript pairs. Three AS variants (p85-a,
p55-a and p50-a) were originally identiﬁed at the human
Table 1. Genomic conservation of AS in humans and mice
Total Non-conserved Genome-conserved Transcript-conserved
Panel A: exon-level conservation of human AS variants, compared with the mouse genome
All exons 199426 27879 (14%) 23412 (12%) 148135 (74%)
AS exons 49842 12196 (25%) 9064 (18%) 28582 (57%)
Total Non-conserved Genome-conserved Transcript-conserved
Panel B: transcript-level conservation of human AS variants, compared with the mouse genome and transcripts
AS variants 20392 8296 (41%) 4410 (21%) 7686 (38%)
AS loci 7601 1716 (23%) 1241 (16%) 4644 (61%)
Transcript-conserved total Non-equally spliced variant ESV Conserved AS
Panel C: higher conservation categories for transcript-conserved AS sequences
AS variants 7686 2631 (34%) 4624 (60%) 431 (6%)
AS loci 4644 885 (19%) 3570 (77%) 189 (4%)
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sponding to p85-a and BC030815 corresponding to
p55-a. The functional domains speciﬁc to Rho GTPase-
activating protein (RhoGAP) (IPR008936) and Src
homology-3 (SH3) (IPR001452) are embedded in the
N-terminal region of p85-a, which extends from the
N-terminal region of p55-a. The p85-a and p55-a variants
appear to have diverged functionally to the extent that
they relay signals from the insulin receptor substrate
(IRS) proteins to PI3-kinase with diﬀerent eﬃciencies
(23). Because it seems natural that such a fundamental
diversiﬁcation would be evolutionarily conserved in both
mice and humans, we were not surprised to identify these
AS variants in mice. Indeed, they were categorized as
‘conserved’ in our study.
Figure 2B shows an example of a locus at which we
identiﬁed previously unknown functional protein changes
caused by AS. The protein products of this locus have
been annotated as cysteinyl-tRNA synthetase (CARS).
A glutathione S-transferase (GST) C-terminal-like
(IPR010987) protein motif was identiﬁed in the
BX647906 AS variant, but was absent from the
BC002880 variant because of the presence of a cassette-
type AS pattern in the second exon of BX647906. The
C-terminal region of GST plays an essential role in sub-
strate activation, and this motif occurs not only in GST
but also in many types of aminoacyl-tRNA synthetases
(aaRSs) (24). Some types of mammalian aaRSs interact
with translational elongation factor (EF)-1 via this GST
C-terminal domain, and this interaction is thought to
facilitate the vectorial transfer of aminoacylated tRNAs.
Thus, the functional roles of the newly identiﬁed AS var-
iants BX647906 and BC002880 may involve the delivery
of the cognate tRNA from CARS to the EF complex,
thereby controlling translation eﬃciency in the cell under
speciﬁc circumstances (25).
Statistical analysis ofevolutionarily conserved ASsequences
Information regarding individual AS sequences and their
annotations is freely available from our database
H-DBAS (http://h-invitational.jp/h-dbas/) (26). We inves-
tigated diﬀerences between the conserved AS sequences
and the total AS sequences and determined that the
cassette-type pattern is more common in conserved AS
sequences and that the retained intron-type pattern is
less common in conserved AS sequences (Table 2, panel
A). Our statistical analysis showed that the average length
of the CDSs of conserved AS sequences was 52 amino
acids, while that of the total AS variants was 87 amino
acids. The frequency of AS-mediated changes in protein
function also diﬀered between the conserved AS variants
(66%) and the total AS variants (45%) (Table 2, panel B).
Because of the increased occurrence of the cassette-type
pattern, conserved AS variants caused more radical
changes than did the general AS population.
As shown in Table 3, we investigated the diﬀerence
between the GO terms of the conserved AS loci and
those of the total AS loci. For this analysis, we examined
protein motifs embedded in the CDSs and considered the
GO terms associated with those motifs. We found that the
GO terms ‘DNA binding (GO:0003677)’, ‘Peroxidase
activity (GO:0004601)’ and ‘Response to oxidative stress
(GO:0006979)’ were signiﬁcantly (P<0.01) over-
represented in conserved AS loci (Table 3, panel A). The
genes having these functions seem to need evolutionarily
invariant AS sequences to play basic roles in keeping cel-
lular homeostasis. The ‘nucleotide-binding’, ‘protein
kinase’ and ‘WD40 protein’ motifs are the most com-
monly aﬀected motifs in conserved AS sequences,
although these motifs are also relatively common in the
general AS population. In contrast, the transforming
growth factor (TGF)-b-stimulated clone-22 (TSC-22)
Dip Bun (IPR000580) motif is signiﬁcantly (P<0.01)
more common in the conserved AS loci than in the general
AS loci (Table 3, panel B). This motif, which has homo-
logues in mice and Drosophila, acts as a transcription
factor and plays a fundamental role in cell diﬀerentiation
(27). Another motif, the basic leucine zipper (bZIP)
Figure 2. Conserved AS sequences, exempliﬁed by (A) PI3-kinase reg-
ulatory subunit and (B) CARS. Constitutive introns are shortened here
and additional details are available in the Results section.
Boxes indicate exons. Filled regions within boxes indicate CDSs
(green), protein motifs (red) and untranslated regions (yellow). The
ESVs shared by humans and mice are indicated by arrows.
Table 2. Comparison of AS features in total and conserved AS loci
Total
AS loci
Conserved
AS loci
Panel A: AS patterns
Total 7601 189
Cassette (Skipped exon) 3584 (35%) 66 (42%)
Internal acceptor (Alternative 30 splice) 1988 (19%) 30 (19%)
Internal donor (Alternative 50 splice) 1990 (20%) 33 (21%)
Mutually exclusive 237 (2%) 4 (2%)
Retained intron 2477 (24%) 26 (16%)
Panel B: Eﬀects of AS on protein function
Total 7601 189
Average diﬀerence in CDS length 87 aa 52 aa
Total eﬀects of AS on function 3395 (45%) 125 (66%)
Protein-motif alterations 2423 86
GO alterations 1078 30
Sub-cellular localization changes 2305 75
Transmembrane domain changes 444 16
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the conserved AS loci (Table 3, panel B). In eukaryotes,
the bZIP transcription factor is responsible for initiating
cellular responses to ultraviolet (UV) damage and osmotic
stress (28). Because the switch of these functional motifs is
essential to basic cellular functions, the corresponding AS
sequences should also be conserved between species.
These results suggest that the functions of AS sequences
diﬀer between conserved AS variants, which constitute the
core dataset of the AS sequences and have conserved
diversiﬁcation of gene functions, and other AS variants.
In other words, a distinct subset of protein motifs appears
to be responsible for the functional diversity of conserved
and species-speciﬁc gene functions. Classiﬁcation of the
AS variants is necessary to further address this issue.
Experimental validationof retained introns
After selecting and manually annotating the AS variants,
we sought to understand why there was such a large popu-
lation of non-conserved variants. One possibility is that
these non-conserved variants are artefacts derived from
aberrant cDNA cloning (e.g. cDNAs produced from
incompletely spliced mRNAs or genomic DNA contami-
nants). Sequence information is insuﬃcient to distinguish
truly functional retained-intron type AS sequences (which
are less common among conserved AS sequences) from
the rest of the population.
We selected 14 retained-intron AS variant pairs
from the transcript-conserved population, 15 from the
genome-conserved population, and 5 from the non-
conserved population, which were manually annotated
as ‘highly likely protein coding’ sequences. In the
transcript-conserved population all of the exons were con-
served at the transcriptional level (i.e. there were corre-
sponding mouse cDNAs for both variants). In the
genome-conserved population, there were no correspond-
ing mouse transcripts but the corresponding genomic
sequences for all the related exons were conserved. In
the non-conserved population, at least one of the related
exons was not conserved. We determined the expression
patterns of the selected variants in 20 types of human
tissues by using semi-quantitative real-time RT–PCR.
As a control, we performed the same series of experiments
on adjacent exons separated by moderately long introns.
We observed no evidence of immature splicing in any of
the controls. PCR products corresponding to the retained
introns were observed in at least one tissue for 14 of the 14
transcript-conserved variants, for three of the 15 genome-
conserved variants and for three of the ﬁve non-conserved
variants. A wide variety of expression patterns was
observed. For example, we observed ubiquitous expression
of both type of some AS variants (Figure 3A, upper panel),
whereas we observed the mutually exclusive expression of
other AS variants in a tissue-preferred manner (Figure 3A,
lower panel). These results suggest that a signiﬁcant popu-
lation of cDNAs, even those resulting from retained-intron
AS variants, were derived from real transcripts. The overall
expression patterns and mutual dependence of the AS var-
iants appear to be controlled.
We further investigated whether transcripts containing
retained-intron AS sequences were translated into pro-
teins. We did this by recovering RNAs from actively trans-
lating ribosomal fractions (i.e. polysomal fractions) in a
human promyelocytic leukaemia cell line, HL60, with
sucrose density-gradient puriﬁcation (Figure 3B). RNAs
puriﬁed from fractions 7–10 were analysed with real-time
RT–PCR. RT–PCR of total RNA revealed that 14 of the
transcript-conserved retained introns that were expressed
in at least one tissue were expressed in HL60 cells. For
nine of these, clear bands of the appropriate size were
produced by RT–PCR of the polysome fractions
(Figure 3C and D and Supplementary Table 3B).
Interestingly, even among non-conserved AS sequences,
we observed evidence of the translation of retained-
intron AS sequences. Although further analysis is neces-
sary, we have shown that even retained-intron AS var-
iants, which were previously considered dubious cDNAs,
are often expressed as proteins. Future investigators
should therefore annotate these full-length cDNAs
rather than automatically discard them.
Characterization ofnon-conserved exons
To further characterize the non-conserved exons, we ﬁrst
compared the characteristic features of the non-conserved
Table 3. GO terms and protein motifs frequently observed at conserved AS loci
GO ID Deﬁnition Number of
conserved AS loci
Total number
of AS loci
P
Panel A: GO terms
GO:0003677 DNA binding 17 333 0.0085
 
GO:0004601 Peroxidase activity 3 14 0.0077
 
GO:0006979 Response to oxidative stress 3 14 0.0077
 
InterPro ID Deﬁnition Number of conserved AS loci Total number of AS loci P
Panel B: protein motifs
IPR004827 Basic-leucine zipper
transcription factor
3 4 0.0005
 
IPR000580 TSC-22/Dip/Bun 2 3 0.0057
 
P-values were calculated using Fisher’s exact test. They indicate the signiﬁcance of the diﬀerence between the ratios to the
conserved AS loci (189) and the total AS loci (7601).
 P<0.01.
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exon data set consisted of the genome level and above, and
our results showed that the majority of non-conserved
exons are located at the 50-end of the transcript and
appear to function as AS exons (Supplementary
Table 5). Consistent with our ﬁndings, recent studies
have found that alternative 50-exons derived from alterna-
tive promoters are abundant in humans and are often not
evolutionarily conserved (29). In contrast, the coding
regions of non-conserved exons overlap less frequently
with AS exons than with constitutively spliced (CS)
exons (Table 4). It is likely that previous studies reported
overall higher frequencies for non-conserved exons among
AS exons because the number of non-conserved exons is
greatest at the 50-ends of non-coding exons.
We also observed that non-conserved exons were
excluded from protein-motif regions (Table 4). Even in
cases where non-conserved AS exons overlap with protein
motifs, the categories of overlapping motifs diﬀer strik-
ingly from those motifs overlapping conserved AS
sequences. The most frequently observed protein motif
in non-conserved AS exons was the KRAB box
(IPR001909) (Supplementary Table 6) (30). This observa-
tion is consistent with the results of a previous study
reporting that this motif, which is a well-known protein
interaction domain, was signiﬁcantly enriched in the sites
of alternative splicing (31). The KRAB-type zinc ﬁnger is
thought to control the transcription of the sex-determining
region Y (SRY/Sry) gene and is therefore essential for the
determination and diﬀerentiation of the testis (32). The
fact that KRAB motifs tend to overlap with non-con-
served AS exons may underscore the evolutionary unique-
ness of the human transcriptional regulatory network in
the reproductive system. A few protein motifs, including
the GAGE motif (IPR008625), nuclear-pore-complex-
interacting motif (IPR009443), phospholipase A2 active
site motif (IPR013090) and the T-complex 11 motif
(IPR008862), were also identiﬁed only in non-conserved
AS exons (Supplementary Table 6). The GAGE motif is
speciﬁc to humans and the nuclear-pore-complex-interact-
ing motif is speciﬁc to primates (33,34). We further exam-
ined the expression patterns of these genes having GAGE,
nuclear-pore-complex-interacting, phospholipase A2,
active site and T-complex 11 motifs by using our expres-
sion proﬁling database H-ANGEL (Human Anatomical
Gene Expression Library) (35). We found that the genes
containing the GAGE and T-complex motifs were
preferentially expressed in testis, that the expression
pattern of genes containing the nuclear-pore-complex-
interacting motif was ubiquitous and that there was no
data on the expression pattern of genes containing the
phospholipase-A2-active-site motif (Figure 4). Although
the functions of GAGE-motif-containing genes are poten-
tially very interesting, all that is known about that them is
that they are primate speciﬁc. We were unable to investi-
gate the AS of the GAGE motifs in this study because
their parent genes are not found in mice (also see
Supplementary Table 6). The parent genes for the
T-complex-11 motifs, in contrast, are found in both
humans and mice. Furthermore, human and mouse
TCP11, which encodes the receptor for fertilization-pro-
moting peptide (FPP), is reported to play an important
role in sperm function (36). In any case, it is interesting
that the GAGE and T-complex-11 motifs, which are
enriched in the non-conserved AS exons, were associated
with a species-speciﬁc factor involved in the reproductive
system.
Our results also show that non-conserved exons are
more frequently related to retrotransposons (Table 4).
This observation is not surprising because human retro-
transposons are primate speciﬁc (Alu) and mouse retro-
transposons are rodent speciﬁc (37). Exonic-splicing
enhancers (ESEs) are ubiquitously scattered in human
AS variants (Table 4), so we could not observe the relation
between ESE conservation and splicing (38). We found no
clear diﬀerences between the non-conserved and conserved
Figure 3. Experimental validation of AS human transcripts by using
the retained-intron pattern. (A) RNA expression of retained-intron AS
sequences in 20 human tissues (1, adrenal gland; 2, bone marrow; 3,
brain, cerebellum; 4, brain, whole; 5, fetal brain; 6, fetal liver; 7, heart;
8, kidney; 9, liver; 10, lung, whole; 11, placenta; 12, prostate; 13, sali-
vary gland; 14, skeletal muscle; 15, testis; 16, thymus; 17, thyroid gland;
18, trachea; 19, uterus and 20, spinal cord). The upper panel exempliﬁes
‘ubiquitous’ retained-intron AS sequences and the lower panel exempli-
ﬁes ‘tissue-preferred’ retained-intron AS sequences. (B) RT–PCR ana-
lysis using polysomal fractions isolated from the human promyelocytic
leukaemia cell line HL60. (C) RNA expression of retained-intron AS
sequences mixed with translating ribosome fractions (i.e. polysome frac-
tions) from the HL60 cell line. (D) Number of expressed transcripts in
each conserved category.
6392 Nucleic Acids Research, 2008, Vol. 36, No. 20exons in terms of their length distributions, base composi-
tions, absolute base sizes and relative positions in introns,
or frequencies of particular AS relationships (data not
shown).
DISCUSSION
We performed a large-scale comparative study of the AS
variants in human transcripts, a study based on comple-
tely sequenced and intensively annotated full-length
human and mouse cDNAs. Our dataset of AS full-
length cDNAs is unique in that all combinations of AS
exons have been deﬁned as single entities in the complete
form of the transcript. To the best of our knowledge, this
is the largest available dataset of its kind. Although some
of the AS variants identiﬁed here, especially those having
an easily detectable internal AS pattern like a cassette,
have been previously identiﬁed with EST-based or
microarray-based approaches and are in the RefSeq and
Ensembl databases, the previous identiﬁcation of those
variants was based on the interpretation of fragmented
partial cDNA sequences and computational gene predic-
tions. Indeed, 12710 of the 13705 cassette AS exons iden-
tiﬁed in this study (93%) had been identiﬁed in more than
one EST-based study (Supplementary Table 7A). On the
other hand, only 11% of the cassettes AS exons we iden-
tiﬁed in this study are in the RefSeq database and only
38% of them are in the Ensembl database (Supplementary
Table 7B). We think that one of the major barriers to these
AS exons being included in the representative gene models
has been a lack of precise annotations, which are now
available in our dataset. Our manually and computation-
ally inspected data allowed us to examine the genome-
wide features of AS sequences in a far more reliable
manner than was previously possible, and our ﬁndings
will enhance our understanding of the complex biological
nature of AS sequences. A very interesting paper based on
our AS database revealing the relation between transcrip-
tional start sites (TSSs) and AS has already been published
(39).
This study provides the ﬁrst glimpse of the evolutionary
turnover of AS sequences in full-length transcripts.
Throughout evolution, the genomes of higher eukaryotes
have expanded and mutations have been introduced by
environmental factors (e.g. ultraviolet radiation) or inter-
nal factors (e.g. transposons). Mammals and other higher
eukaryotes are thought to have accumulated numerous
novel AS variants, and many AS sequences identiﬁed in
this study appear to have occurred in a human-speciﬁc
manner. By integrating information about evolutionary
conservation with functional annotations, we have deter-
mined that non-conserved exons appear to have unexpect-
edly been excluded from the CDSs (Table 4). We had
hypothesized that the CDSs would be more likely to con-
tain non-conserved AS exons than conserved ones because
the selective pressure against their biological functions is
weak. We however found evidence of selective pressure
against non-conserved AS exons in the CDS. Thus, it is
likely that exons are easily generated by alternative spli-
cing after speciation but are more likely to produce mal-
functioning proteins when they occur in the CDS. It is also
interesting that most AS variants are produced in the
brain and testis (40). Because these tissues contain large
numbers of neurons and sperm cells that could be func-
tionally served as mutual substitutions or because varia-
bility itself may be important in these tissues, the
occasional malfunction of individual proteins might be
relatively well tolerated there. Thus, cells in the brain
and testis might take advantage of the opportunity to
experiment with AS variants, and this experimentation
might act as a driving force in evolution and speed the
process of speciation.
We shall soon overcome the current problems asso-
ciated with the use of full-length cDNA data, the greatest
of which—the limited number of sequences available—
prevents us from analysing all AS variants. Researchers
are already initiating large-scale projects by, using the next
generation of DNA sequencers (e.g. Illumina 1G and
SOLiD) to sequence previously isolated and partially
Table 4. Relationship between conservation and splicing in human alternatively spliced variant exons
Total CDS-related Protein-motif-related Retrotransposon-related Exonic-splicing-enhancer-related
C/CS exons 133901 95583 (71%) 27805 (21%) 2523 (2%) 130104 (97%)
C/AS exons 37646 20805 (55%) 6192 (16%) 2308 (6%) 35702 (95%)
NC/CS exons 15683 7030 (45%) 1898 (12%) 2549 (16%) 14961 (95%)
NC/AS exons 12196 3516 (29%) 812 (7%) 4544 (37%) 11701 (96%)
All exons 99426 126934 (64%) 36707 (18%) 11924 (6%) 192468 (97%)
C, conserved; NC, non-conserved.
Figure 4. Expression pattern of parent genes in H-ANGEL that have
GAGE or T-complex 11 motifs. The expressed pattern was examined
by iAFLP, GeneChip and BodyMap-EST. The height of bars indicates
the percentage in 10 tissue categories. The name of tissues are as fol-
lows (from the left): neural, blood/spleen/lymph node dissection
(LND), dermal/connective, placenta/testis/ovary, muscle/heart, sto-
mach/colon, liver, lung, kidney/bladder and endocrine/exocrine. The
expressed speciﬁc tissue here was testis according to more detailed
categories in H-ANGEL.
Nucleic Acids Research, 2008, Vol. 36, No. 20 6393sequenced cDNA clones. The same type of full-length
cDNA data now available for mice and men will soon
become available for other mammals. Further enrichment
of the expression information will also allow us to pre-
cisely analyse in what tissue the species-speciﬁc AS
sequences are utilized. The current presumption that the
products of AS are found most frequently in brain and
testis should be tested by non-EST-based sampling-bias-
free analysis. Cataloguing full-length cDNAs and creating
related databases are the ﬁrst steps toward understanding
how AS variants contribute to the functional and evolu-
tionary diversiﬁcation of gene functions.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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